Tetravalent anti-CD20/CD3 bispecific antibody for the treatment of B cell lymphoma - ScienceDirect
Raji-Null cells | ADCC targets | InvivoGen
CD20 - Wikipedia
Immunohistochemistry and Flow Cytometry in Bone Marrow Haematopathology (Chapter 19) - Diagnostic Bone Marrow Haematopathology
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
PLOS ONE: Flow cytometric discrimination of seven lineage markers by using two fluorochromes
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Frontiers | Adjacent Cell Marker Lateral Spillover Compensation and Reinforcement for Multiplexed Images | Immunology
Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. - Abstract - Europe PMC
The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
Pan Lymphoma cocktail Antibody- Biocare Medical
A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies. - Abstract - Europe PMC
Cd marker handbook
A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys | Scientific Reports